mTOR Pathway and mTOR Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) - Image 1

£146.56

Humana mTOR Pathway and mTOR Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)

Name: mTOR Pathway and mTOR Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)
Brand: Humana
Price: 146.56 GBP
Availability: InStock

Oncology

It has never been this cheap. We have no record of a lower price.

£147 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 6 days • 6 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 6 days • 1 price levels

Days at Price

Price Analysis

Most common price: £147 (6 days, 100.0%)

Price range: £147 - £147

Price levels: 1 different prices over 6 days

Description

The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment – targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. In mammalian cells, mTOR exists in at least two multi-protein complexes that have critical roles in regulating cellular homeostasis and survival. As with many other areas of science, discovery of TOR signaling was fortuitous. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island). Rapamycin was rst discovered to be a potent antifungal agent and next as an immune suppressive drug. It was only later that it was found to be active as an antitumor agent in non-clinical models; although it was not developed for this indication. The history of rapamycin presents one of the rst examples of chemical genetics. From the Back Cover mTOR Pathway and mTOR Inhibitors in Cancer Therapy provides an up-to-date survey of the rapidly advancing field of cancer therapy. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment – targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even further collaboration between investigators in these two disciplines. In this work, experts in TOR signaling have contributed in two thematic areas: mTOR Signaling and Cancer Therapy (chapters 1 - 8) and Therapeutic Targeting Downstream of mTOR (chapter 9 – 13). All chapters of mTOR Pathway and mTOR Inhibitors in Cancer Therapy are completely new or have been extensively updated by their authors; and we are indebted to all authors who have exemplified the links between these 2 thematic areas.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 1617796948
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Publication Date: 13 October 2012
Listed Since: 13 September 2012

Barcode

No barcode data available

Humana mTOR Pathway and mTOR Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

mTOR: Methods and Protocols: 821 (Methods in Molecular Biology, 821)

mTOR in Human Diseases

TOR: Target of Rapamycin: 279 (Current Topics in Microbiology and Immunology, 279)

TCTP/tpt1 - Remodeling Signaling from Stem Cell to Disease: 64 (Results and Problems in Cell Differentiation, 64)

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy (Cancer Drug Discovery and Development)

TGF-β Signaling: Methods and Protocols: 1344 (Methods in Molecular Biology, 1344)

Cancer Cell Signaling: Targeting Signaling Pathways Toward Therapeutic Approaches to Cancer

Targeted Therapies in Oncology

TGF-β Signaling: Methods and Protocols: 1344 (Methods in Molecular Biology, 1344)

Tumor Suppressor Genes: Volume 2: Regulation, Function, and Medicinal Applications: 223 (Methods in Molecular Biology, 223)

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Prognostic and Therapeutic Applications of RKIP in Cancer

Allostery: Methods and Protocols: 796 (Methods in Molecular Biology, 796)

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Springer - Molecular Therapies of Cancer Textbook

MicroRNAs: Key Regulators of Oncogenesis

Caspases,Paracaspases, and Metacaspases: Methods and Protocols: 1133 (Methods in Molecular Biology, 1133)

Advancing Development of Synthetic Gene Regulators: With the Power of High-Throughput Sequencing in Chemical Biology (Springer Theses)

Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology (Cancer Drug Discovery and Development)